Red Reef Advisors »

Taysha Gene Therapies shares owned by Red Reef Advisors

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Red Reef Advisors from 13F filings

Historical chart of Red Reef Advisors investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Red Reef Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Red Reef Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $363k 66k 5.50

More positions owned by Red Reef Advisors

NVIDIA Corporation (NVDA)
Eli Lilly & Co. (LLY)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Broadcom (AVGO)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Innovator Etfs Trust Us Eqty Pwr Buf (PDEC)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Apple (AAPL)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Schwab Strategic Tr Fundamental Intl (FNDF)
Ishares Tr Us Sml Cap Eqt (SMLF)
Innovator Etfs Trust Quity Managd Flr (SFLR)

View all positions for Red Reef Advisors

Top funds holding Taysha Gene Therapies

RA Capital Management
venBio Select Advisor
BlackRock
Rtw Investments
Vestal Point Capital
Goldman Sachs Group
FMR
Vanguard Group
State Street Corporation
Siren
Octagon Capital Advisors
Polar Capital Holdings
Barclays
Geode Capital Management
D. E. Shaw & Co

View all funds holding Taysha Gene Therapies